$0.935700
-0.01-1.14%
At Close: -
$0.923600
-0.01-1.29%
After Hours: Jul 5, 7:54 PM EDT
15 minutes delayed
Akebia Therapeutics
AKBANASDAQ
Akebia Therapeutics (NASDAQ:AKBA) Stock, Insider Trading Activity
Akebia Therapeutics: Insider buying and selling updated today.
Institutional Shares Held
17.842M
Institutional Percentage Held
8.51%
| May 14, 2024 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -12.016K | $1.26 | -$15.14K | SELL | -1.81% | 651.243K | May 13 | View |
| May 14, 2024 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -34.84K | $1.26 | -$43.90K | SELL | -4.93% | 672.092K | May 13 | View |
| May 09, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -27K | $1.15 | -$31.05K | SELL | -3.88% | 668.84K | Aug 25 | View |
| Mar 01, 2024 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -8.661K | $1.58 | -$13.68K | SELL | -1.21% | 706.932K | Feb 29 | View |
| Mar 01, 2024 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -5.974K | $1.58 | -$9.44K | SELL | -0.89% | 663.259K | Feb 29 | View |
| Mar 01, 2024 | John P Butler | CEO AND PRESIDENT | -46.57K | $1.58 | -$73.58K | SELL | -2.16% | 2.104508M | Feb 29 | View |
| Mar 01, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -7.169K | $1.58 | -$11.33K | SELL | -1.02% | 695.84K | Feb 29 | View |
| Feb 29, 2024 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -7.411K | $1.52 | -$11.26K | SELL | -1.10% | 669.233K | Feb 27 | View |
| Feb 29, 2024 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -10.744K | $1.52 | -$16.33K | SELL | -1.48% | 715.593K | Feb 27 | View |
| Feb 29, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -8.367K | $1.52 | -$12.72K | SELL | -1.18% | 703.009K | Feb 27 | View |
| Feb 29, 2024 | John P Butler | CEO AND PRESIDENT | -37.733K | $1.52 | -$57.35K | SELL | -1.72% | 2.151078M | Feb 27 | View |
| Feb 02, 2024 | John P Butler | CEO AND PRESIDENT | 557.011K | $1.68 | -$78.10K | GRANT | 34.13% | 2.188811M | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 177.889K | $1.68 | -$40.84K | GRANT | 33.34% | 711.376K | Jan 31 - Feb 01 | View |
| May 25, 2023 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | 136.814K | $1.22 | -$77.27K | GRANT | 35.30% | 524.344K | May 24 - May 25 | View |
| May 25, 2023 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | 104.522K | $1.22 | -$116.76K | GRANT | 22.26% | 574.037K | May 24 - May 25 | View |
| May 18, 2023 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -63.567K | $1.07 | -$67.89K | SELL | -10.70% | 530.487K | May 16 | View |
| May 18, 2023 | David A Spellman | SVP, CFO AND TREASURER | -63.567K | $1.07 | -$67.89K | SELL | -12.46% | 446.483K | May 16 | View |
| Mar 03, 2023 | John P Butler | CEO AND PRESIDENT | -91.868K | $0.88 | -$80.61K | SELL | -5.34% | 1.6288M | Mar 01 | View |
| Mar 03, 2023 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -13.034K | $0.88 | -$11.44K | SELL | -4.34% | 287.53K | Mar 01 | View |
| Mar 03, 2023 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -14.123K | $0.88 | -$12.39K | SELL | -2.32% | 594.054K | Mar 01 | View |
| Mar 03, 2023 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -20.412K | $0.88 | -$17.91K | SELL | -7.04% | 269.515K | Mar 01 | View |
| Mar 03, 2023 | David A Spellman | SVP, CFO AND TREASURER | -7.21K | $0.88 | -$6.33K | SELL | -1.39% | 510.05K | Mar 01 | View |
| Mar 01, 2023 | John P Butler | CEO AND PRESIDENT | -38.632K | $0.81 | -$31.42K | SELL | -2.20% | 1.720668M | Feb 27 | View |
| Mar 01, 2023 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -7.539K | $0.81 | -$6.13K | SELL | -1.22% | 608.177K | Feb 27 | View |
| Mar 01, 2023 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -10.09K | $0.81 | -$8.21K | SELL | -3.36% | 289.927K | Feb 27 | View |
| Mar 01, 2023 | David A Spellman | SVP, CFO AND TREASURER | -7.539K | $0.81 | -$6.13K | SELL | -1.44% | 517.26K | Feb 27 | View |
| Mar 01, 2023 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -6.677K | $0.81 | -$5.43K | SELL | -2.17% | 300.564K | Feb 27 | View |
| Sep 01, 2022 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -1.147K | $0.36 | -$415.79 | SELL | -0.27% | 418.016K | Aug 31 | View |
| Jun 07, 2022 | Steven C Gilman | — | -4.567K | $0.36 | -$1.65K | SELL | -9.52% | 43.43K | Jun 03 | View |
| Mar 02, 2022 | John P Butler | CEO AND PRESIDENT | 214.099K | $2.17 | -$171.14K | GRANT | 16.61% | 1.503247M | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 44.944K | $2.16 | -$32.56K | GRANT | 26.02% | 217.663K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Violetta Cotreau | SVP, CHIEF ACCOUNTING OFFICER | 36.887K | $2.15 | -$8.50K | GRANT | 111.55% | 69.954K | Feb 28 | View |
| Mar 02, 2022 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | 28.467K | $2.17 | -$46.64K | GRANT | 10.60% | 297.017K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Dell Faulkingham | SVP, CCO | 36.816K | $2.16 | -$28.52K | GRANT | 26.87% | 173.841K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | 28.938K | $2.17 | -$45.62K | GRANT | 10.51% | 304.241K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | David A Spellman | SVP, CFO AND TREASURER | 51.797K | $2.16 | -$17.69K | GRANT | 67.44% | 128.599K | Feb 28 - Mar 01 | View |
| Jan 05, 2022 | Violetta Cotreau | SVP, CHIEF ACCOUNTING OFFICER | -5.833K | $2.29 | -$13.34K | SELL | -14.99% | 33.067K | Jan 03 | View |
| Sep 02, 2021 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -1.042K | $2.83 | -$2.95K | SELL | -0.60% | 171.219K | Aug 31 | View |
| Jun 09, 2021 | Steven C Gilman | — | -4.567K | $3.32 | -$15.16K | SELL | -8.69% | 47.997K | Jun 07 | View |
| Apr 01, 2021 | Dell Faulkingham | SVP, CCO | -952 | $3.40 | -$3.24K | SELL | -0.69% | 137.025K | Apr 01 | View |
| Apr 01, 2021 | David A Spellman | SVP, CFO AND TREASURER | -790 | $3.40 | -$2.69K | SELL | -1.02% | 76.802K | Apr 01 | View |
| Apr 01, 2021 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -1.06K | $3.40 | -$3.60K | SELL | -0.39% | 272.303K | Apr 01 | View |
| Apr 01, 2021 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -1.211K | $3.40 | -$4.12K | SELL | -0.45% | 265.55K | Apr 01 | View |
| Apr 01, 2021 | John P Butler | CEO AND PRESIDENT | -4.109K | $3.40 | -$13.97K | SELL | -0.35% | 1.1832M | Apr 01 | View |
| Apr 01, 2021 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -1.081K | $3.40 | -$3.68K | SELL | -0.63% | 170.761K | Apr 01 | View |
| Mar 02, 2021 | John P Butler | CEO AND PRESIDENT | 187.41K | $3.40 | -$169.77K | GRANT | 19.51% | 1.147789M | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Dell Faulkingham | CCO | 55.251K | $3.40 | -$22.92K | GRANT | 75.10% | 128.825K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | 47.715K | $3.40 | -$48.51K | GRANT | 22.15% | 263.171K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | 47.453K | $3.40 | -$49.40K | GRANT | 22.85% | 255.113K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 62.442K | $3.40 | -$25.67K | GRANT | 63.07% | 161.442K | Feb 26 - Mar 01 | View |
| Jun 09, 2020 | Cynthia Smith | — | 9.133K | $12.10 | -$55.26K | GRANT OR AWARD | 31.82% | 37.833K | Jun 05 - Jun 08 | View |
| Jun 09, 2020 | Steven C Gilman | — | 9.133K | $12.08 | -$55.17K | GRANT OR AWARD | 30.72% | 38.864K | Jun 05 - Jun 08 | View |
| Jun 09, 2020 | Maxine Gowen | — | 9.133K | $12.05 | -$55.03K | GRANT OR AWARD | 60.89% | 24.133K | Jun 05 - Jun 08 | View |
| Jun 02, 2020 | Dell Faulkingham | — | -6.426K | $11.58 | -$74.41K | SELL | -8.03% | 73.574K | Jun 01 | View |
| Mar 02, 2020 | Michel Dahan | — | 58.028K | $8.70 | -$60.66K | GRANT OR AWARD | 39.49% | 204.96K | Feb 28 | View |
| Mar 02, 2020 | Nicole R Hadas | — | 54.95K | $8.70 | -$61.33K | GRANT OR AWARD | 34.82% | 212.756K | Feb 28 | View |
| Mar 02, 2020 | Jason Amello | — | 23.024K | $8.70 | -$60.69K | GRANT OR AWARD | 18.93% | 144.642K | Feb 28 | View |
| Mar 02, 2020 | Karen Tubridy | — | 26.546K | $8.70 | -$30.05K | GRANT OR AWARD | 45.66% | 84.679K | Feb 28 | View |
| Nov 22, 2019 | Steven C Gilman | — | 5.8K | $3.43 | $19.89K | BUY | 24.24% | 29.731K | Nov 20 | View |
| Nov 22, 2019 | Cynthia Smith | — | 15K | $3.52 | $52.80K | BUY | 109.49% | 28.7K | Nov 20 | View |
| Nov 22, 2019 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 27K | $3.58 | $96.66K | BUY | 270.00% | 37K | Nov 20 | View |
| Nov 21, 2019 | John P Butler | CEO AND PRESIDENT | 50K | $3.44 | $172.00K | BUY | 5.76% | 918.779K | Nov 20 | View |
| Nov 21, 2019 | Adrian Adams | — | 50K | $3.41 | $170.50K | BUY | 364.96% | 63.7K | Nov 20 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.